AlzaSyno Life Sciences, established in 2024, is a forward-thinking Contract Research Organization (CRO) dedicated to advancing clinical research and innovation. Led by experts with over a decade of experience in the Pharmaceutical, Biopharmaceutical, Medical Devices, Ayurvedic and Nutraceutical industries.
Dato Prakadeesh Kumar Suriyaprakasam, head of the Plus Max Group of Companies, is a visionary leader recognized for driving innovation and growth across sectors. His strategic foresight and philanthropy have earned him acclaim, as he leads AlzaSyno in embracing cutting-edge technologies and expanding internationally.
Ms. Saranya Suriyaprakasam is an accomplished entrepreneur with over a decade of leadership in biotechnology, clinical research, and international education. She is the Founder & Managing Director of two pioneering Sri Lankan organizations: Braintree, which provides UK degree programs to empower students through globally recognized education, and AlzaSyno Life Sciences, a Contract Research Organization (CRO) supporting pharmaceutical and health product companies with clinical research services for market readiness. Her strategic vision and commitment to excellence have established her as a key figure in advancing both education and clinical research.
Since 2020, Dr. Rahul Shrivastava has advised India’s Ministry of Health, enhancing clinical trial networks and healthcare innovation integration. He mentors innovators, develops research proposals, and trains teams to improve trial readiness. His work emphasizes behavioral change, digital health, telemedicine, and the One Health approach for inclusive research. A strong AI advocate, he leverages data-driven solutions to reduce mortality in underserved areas. Recognized for his contributions to COVID-19 vaccine and medical device development (via BIRAC, DBT, MoST), he has received Best Researcher and Performer Awards. With 17+ publications and an AI-based patent for high-risk pregnancy prediction, Dr. Shrivastava bridges policy and public health, focusing on equitable healthcare access for rural, tribal, and urban slum populations.
Veenu Kumar Mani is a seasoned Clinical Data Management Leader with 24 years of experience steering global operations for Phase I-IV, RWE, and HEOR studies. He possesses deep expertise in EDC systems like Medidata Rave and Oracle Clinical, ePRO, and CTMS. His therapeutic specialization spans oncology, respiratory, and vaccine development.
A certified professional, Veenu is highly adept in regulatory compliance, including GCP, 21 CFR Part 11, GDPR, and data security protocols. He is a proven leader in managing international teams and is skilled in implementing innovative, AI-driven analytics to optimize data quality and delivery. His career is distinguished by a consistent record of successful project execution in complex, global environments.
Jiju is an accomplished Senior Biostatistician and Data Scientist with over 20 years of experience in clinical research, biostatistics, and data science. She has led statistical strategies for numerous clinical trials, developing Statistical Analysis Plans (SAPs), study protocols, and regulatory documents in line with international standards. Skilled in SAS, R, Python, and machine learning. she integrates advanced analytics with predictive modeling to derive meaningful insights from complex datasets. Her expertise spans multiple therapeutic areas, and she has collaborated with cross-functional clinical, medical, and regulatory teams to drive data-driven decision-making and enhance trial outcomes.
Jiju has successfully contributed to regulatory audits and inspections, ensuring compliance and advancing approvals. She has also published projects showcasing her contributions to biostatistics and data science, reinforcing her commitment to innovation and excellence in healthcare research.
We are dedicated to make a difference.
Inspired? We’d love to hear from you
We are dedicated to make a difference. Inspired? We’d love to hear from you
Let’s deliver better clinical trials together to get new treatments to patients faster.
Dato Prakadeesh Kumar Suriyaprakasam, a visionary leader with deep strategic foresight and industry expertise, founded AlzaSyno Life Sciences, establishing it as a premier Contract Research Organization. His global business acumen has driven growth and innovation across multiple sectors, notably under the Plus Max Group of Companies. Through his pioneering initiatives, he has led numerous successful projects, significantly enhancing operational efficiency and market presence. Dato Prakadeesh Kumar’s commitment to societal welfare is reflected in his active philanthropy, earning him the esteemed title of “Dato.” As a strategic visionary, he guides AlzaSyno towards its mission and vision, advocating for the adoption of cutting-edge technologies in clinical research and steering the company’s growth and international expansion.
Ms. Saranya Suriyaprakasam
Ms. Saranya Suriyaprakasam is a seasoned expert in Clinical Research with over 15 years of experience, specializing in Clinical Data Management. She founded Braintree Campus in Colombo, Sri Lanka, a leading tertiary education provider. Her passion for advancing science and medicine led to the creation of AlzaSyno Life Sciences Pvt Ltd, a Contract Research Organization. With a focus on innovative therapies, she aims to enhance patient outcomes and contribute to medical advancements. Her leadership is instrumental in driving AlzaSyno’s mission and vision.
Veenu Kumar Mani is a Clinical Data Management expert with 23 years of experience, specializing in Electronic Data Capture (EDC) systems and the establishment of tailored CDM operations
Jiju Binu, Director of Biostatistics with 15 years of experience, has led clinical research projects, ensuring rigorous data interpretation and regulatory compliance in medical science and drug development
Guhan Anbu is an Assistant Manager with 8 years of Quality Assurance experience in clinical research and pharmaceuticals, ensuring compliance with regulatory standards and Good Clinical Practice (GCP).
Dato Prakadeesh Kumar Suriyaprakasam, head of the Plus Max Group of Companies, is a visionary leader recognized for driving innovation and growth across sectors. His strategic foresight and philanthropy have earned him acclaim, as he leads AlzaSyno in embracing cutting-edge technologies and expanding internationally.
Saranya Suriyaprakasam is a Clinical Research expert with over 15 years of experience, specializing in Clinical Data Management. She founded Braintree Campus in Colombo, Sri Lanka, and established AlzaSyno Life Sciences Pvt Ltd to advance innovative therapies and enhance patient outcomes, driving the company’s mission and vision.
Privacy Polict
Terms of Use
Address:
Address Lane, Address
Phone:
0121 3235 443 333
Email:
example@x.com
© 2024 | All Rights Reserved | Alzasyno Life Sciences Private Limited
Web by VG Group
Phone:
+91 9266859299
Mail us:
contact@alzasyno.com
Address:
Corporate Office
No. 86/18, Royal complex, Seetharampalayam, Tiruchengode, Namakkal Dist Tamil Nadu – 637209
Gurgaon Office
378-379, Electronic City, Phase IV, Udyog Vihar, Sector 19, Gurugram, Haryana – 122015
Copyright © 2024 Alzasyno Life Sciences. All rights reserved.
Web by VG Group
